ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the American college of cardiology/American heart association task force on performance measures and task force on practice guidelines

Circulation

Volumn 129, Issue 22, 2014, Pages 2329-2345

  Anderson, Jeffrey L ^a   Heidenreich, Paul A ^b   Barnett, Paul G ^b   Creager, Mark A ^c   Fonarow, Gregg C ^d   Gibbons, Raymond J ^e   Halperin, Jonathan L ^f   Hlatky, Mark A ^g   Jacobs, Alice K ^h   Mark, Daniel B ⁱ   Masoudi, Frederick A ^j   Peterson, Eric D ⁱ   Shaw, Leslee J ^k   Albert, Nancy M ⁿ   Chan, Paul S ^p   Curtis, Lesley H ^l   Ferguson, T Bruce ^p   Funk, Marjorie ^p   Ho, P Michael ^p   Jenkins, Kathy J ^p   O'Brien, Sean ^p   Russo, Andrea M ^p   Ting, Henry H ^p   Varosy, Paul D ^p   Bozkurt, Biykem ^p   Brindis, Ralph G ^o   DeMets, David ^p   Fleisher, Lee A ^p   Gidding, Samuel S ^p   Guyton, Robert A ^p   Kovacs, Richard J ^p   Ohman, E Magnus ⁱ   Pressler, Susan J ^p   Sellke, Frank ^m   Shen, Win Kuang ^p   Wijeysundera, Duminda N ^p   more..

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b Technicolor Palo Alto   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAYO CLINIC   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BOSTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF COLORADO   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m RHODE ISLAND HOSPITAL   (United States)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p NONE

more..

Author keywords

AHA Scientific Statements; cost; quality indicators; quality measurement

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL FEE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYSTEMATIC REVIEW (TOPIC);

AHA SCIENTIFIC STATEMENTS; COST; QUALITY INDICATORS; QUALITY MEASUREMENT;

COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 84901935185     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000042     Document Type: Article

References (45)

1. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation. 2005;111:1703-12.
2. Spertus JA, Bonow RO, Chan P, et al. ACCF/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Circulation. 2010;122:2091-106.
3. Schwartz JA, Pearson SD. Cost consideration in the clinical guidance documents of physician specialty societies in the United States. JAMA Intern Med. 2013;173:1091-7.
4. The Henry J. Kaiser Family Foundation. Health care costs: a primer. Available at: http://kff.org/health-costs/report/health-care-costs-a-primer/. Accessed February 13, 2013.
5. Leavitt MO. Testimony before the Committee on Ways and Means, US House of Representatives. February 18, 2005. Available at: http://www. hhs.gov/asl/testify/t050217a.html. Accessed March 26, 2013.
6. National Institute for Health Care Management US health care spending: the big picture. NIHCM Foundation Data Brief. May 2012. Available at: http://www.nihcm.org/images/stories/Data-Brief-1-Big-Picture-FINAL.pdf. Accessed November 12, 2013.
7. Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group. National health expenditure accounts. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/ Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/ tables.pdf. Accessed November 12, 2013.
8. National Research Council. Best care at lower cost: the path to continuously learning health care in America. 2013. Available at: http://www.nap. edu/openbook.php?record-id=13444. Accessed February 13, 2013
9. Matlock DD, Groeneveld PW, Sidney S, et al. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013;310:155-62.
10. OECD Factbook 2013: Economic, Environmental and Social Statistics. Organisation for Economic Cooperation and Development Publishing. Available at: http://www.oecd-ilibrary.org/economics/ oecd-factbook-18147364. Accessed February 13, 2013.
11. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477-81.
12. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354-e471.
13. Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial. Circulation. 2011;124:1239-49.
14. Himmelstein DU, Thorne D, Warren E, et al. Medical bankruptcy in the United States, 2007: results of a national study. Am J Med. 2009;122:741-6.
15. Rosenbaum L, Lamas D. Cents and sensitivity - teaching physicians to think about costs. N Engl J Med. 2012;367:99-101.
16. Matchar DB, Samsa GP. The role of evidence reports in evidence-based medicine: a mechanism for linking scientific evidence and practice improvement. Jt Comm J Qual Improv. 1999;25:522-8.
17. Neumann PJ. Why don't Americans use cost-effectiveness analysis? Am J Manag Care. 2004;10:308-12.
18. Matchar DB, Mark DB. Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133 Suppl 6:132-40S.
19. Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest. 2006;129:182-7.
20. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275-83.
21. Cost-Effectiveness in Health and Medicine. Gold MR, ed. New York, NY: Oxford University Press; 1996.
22. Chapman RH, Berger M, Weinstein MC, et al. When does qualityadjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004;13:429-36.
23. Lee CP, Chertow GM, Zenios SA. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health. 2009;12:80-7.
24. World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE): cost-effectiveness thresholds. Available at: http://www. who.int/choice/costs/CER-thresholds/en/index.html. Accessed March 26, 2013
25. Van Hout BA, Al MJ, Gordon GS, et al. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994;3:309-19.
26. Walker D. Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan. 2001;16:113-21.
27. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA. 2002;287:2809-12.
28. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43:5-14.
29. Papadakis S, Oldridge NB, Coyle D, et al. Economic evaluation of cardiac rehabilitation: a systematic review. Eur J Cardiovasc Prev Rehabil. 2005;12:513-20.
30. Kruper L, Kurichi JE, Sonnad SS. Methodologic quality of cost-effectiveness analyses of surgical procedures. Ann Surg. 2007;245:147-51.
31. Spiegel BM, Targownik LE, Kanwal F, et al. The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. Gastroenterology. 2004;127:403-11.
32. Blackmore CC, Magid DJ. Methodologic evaluation of the radiology costeffectiveness literature. Radiology. 1997;203:87-91.
33. Ofman JJ, Sullivan SD, Neumann PJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9:53-61.
34. Pignone M, Saha S, Hoerger T, et al. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005;142:1073-9.
35. Au F, Prahardhi S, Shiell A. Reliability of two instruments for critical assessment of economic evaluations. Value Health. 2008;11:435-9.
36. Diamond GA, Kaul S. Cost, effectiveness, and cost-effectiveness. Circ Cardiovasc Qual Outcomes. 2009;2:49-54.
37. Gerkens S, Crott R, Cleemput I, et al. Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Int J Technol Assess Health Care. 2008;24:318-25.
38. Weintraub WS, Cohen DJ. The limits of cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2009;2:55-8.
39. Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124:967-90.
40. Heidenreich PA. Economics in cardiovascular medicine. In: Chatterjee K, ed. Cardiology. London, UK: Jaypee Brothers Medical Publishers; 2013:1976-85.
41. Hlatky MA, Mark DB. Economics in cardiovascular disease. In: Zipes DP, ed. Heart Disease. Philadelphia, PA: Elsevier Saunders; 2005: 20-34.
42. Greenberg D, Rosen AB, Wacht O, et al. A bibliometric review of costeffectiveness analyses in the economic and medical literature: 1976-2006. Med Decis Making. 2010;30:320-7.
43. Neumann PJ, Greenberg D, Olchanski NV, et al. Growth and quality of the cost-utility literature, 1976-2001. Value Health. 2005;8:3-9.
44. O'Kane M, Buto K, Alteras T, et al. Demanding value from our health care: motivating patient action to reduce waste in health care. Available at: http://www.iom.edu/PatientsForValue. Accessed March 9, 2014.
45. Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:268-310.